Sponsoring the 2019 Colorado Protein Stability Conference

2019/07/22

Coriolis Pharma is proud to be sponsor of the “2019 Colorado Protein Stability Conference: 25th Anniversary”.

https://www.regonline.com/builder/site/default.aspx?EventID=2537791

On Wednesday 30th July 2019, our CSO Andrea Hawe will be presenting a poster on a “Novel high-throughput 96-well plate assay for polysorbate quantification in biopharmaceutical products”.

Our CTO Tim Menzen will present on “Recent advances in submicron and micron particle analysis for biopharmaceuticals” on Tuesday 1st August 2019 in the session on Formulation, Analysis and Processing of Therapeutic Proteins (Chaired by Andrea Hawe).

Furthermore, there will be talks from Coriolis’ scientific advisors:
Wolfgang Friess, Ludwig-Maximilians Univ. New insights into the aggregation of monoclonal antibodies at the air-liquid interface

Christian Schöneich, Univ. of Kansas Novel pathways of oxidative protein degradation: a tale of radicals, tungstate and excipients

Gerhard Winter, Ludwig-Maximilians Univ. Protein-drug formulation: From the 1990's until today -- A winding road upwards

Coriolis offers AUC under GMP

News

Coriolis Pharma Adds Analytical Ultracentrifugation for Release Testing to its Service Offerings

Coriolis Pharma offers Analytical Ultracentrifugation (AUC) for biologics and virus-based drug products from early-stage development to post-market monitoring.

Modeling the future of Lyophilization

News

Modelling The Future Of Lyophilization

Coriolis experts Andrea Arsiccio and Brecht Vanbillemont publish article on lyophilization modelling in "the Medicine Maker".

Donations 2023

News

Coriolis donates to aid organizations

Coriolis spreads the Christmas spirit and donates to organizations that help people in need, fight for a healthy nature, or improve our society as a whole

Tim Menzen

News

Tim Menzen honored by JPharmSci as Outstanding Early Career Scientist

The Editorial Staff and the American Pharmacists Association have been recognizing outstanding outstanding early career scientists for publishing their most original and significant scientific findings ...

Gideon Kersten Leiden University

News

Coriolis Pharma re-establishes Chair in Vaccine development at Leiden University

Leiden University re-appoints Prof. Dr. Gideon Kersten to the Chair in Vaccine development for a third 5-year term.

Coriolis News

News

Coriolis Pharma announces strategic growth partnership with KKR and Frontier Biosolutions

Coriolis Pharma secures investment from KKR to support next steps in growth and to expand global footprint.

Johannes Clemens

News

Coriolis Pharma appoints Johannes Clemens as new Head of Business Development

Coriolis Pharma appoints Johannes Clemens as new Head of Business Development. He will be responsible for expanding Coriolis’ worldwide activities and services, including client business and the establishment of new collaborative partnerships.

Continued Freeze Drying

News

Coriolis Pharma and RheaVita join forces in collaboration for continuous and controlled freeze-drying technology

Coriolis Pharma extends its service portfolio by integrating RheaVita’s single vial unit (SVU) technology for continuous and controlled freeze-drying to stabilize novel modalities as part of biologics drug product development for clients.

Coriolis sponsors GFK sailing team

News

Coriolis sponsors GFK sailing team

Coriolis sponsors GFK sailing team at H-Boat World Cup race from August 1-4, 2023, on Lake Garda in Italy. We keep our fingers crossed.

Coriolis contributes to CNATM

News

Coriolis contributes to CNAT-M

Coriolis contributes to CNATM with drug product development expertise and formulation know-how to enable the transformation from innovative molecules towards drug products suitable for human application.